PANews reported on February 25th that, according to MLM monitoring, a trader named "Ray" has turned bullish ahead of Nvidia's earnings release. He has already boughtPANews reported on February 25th that, according to MLM monitoring, a trader named "Ray" has turned bullish ahead of Nvidia's earnings release. He has already bought

A trader has bet on Nvidia's earnings report and has already established a long position of approximately 147,000 shares of NVDA on Hyperliquid.

2026/02/25 11:08
1 min read

PANews reported on February 25th that, according to MLM monitoring, a trader named "Ray" has turned bullish ahead of Nvidia's earnings release. He has already bought approximately 147,000 shares of NVDA stock on Hyperliquid through two wallets, with a notional value of $28.3 million. In addition, the trader has been continuously buying approximately $4 million worth of Nvidia stock in batches using a TWAP strategy, indicating a continued bullish expectation for the earnings report. Nvidia is expected to release its earnings report this Thursday morning, and option pricing suggests that its stock price may fluctuate by up to 6% this week. However, in the past four quarters, despite Nvidia's better-than-expected results in three quarters, the stock price has consistently fallen the day after the earnings release.

Market Opportunity
Bullish Degen Logo
Bullish Degen Price(BULLISH)
$0.006018
$0.006018$0.006018
+4.55%
USD
Bullish Degen (BULLISH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.